EAM Investors’s Chemours CC Stock Holding History

EAM Investors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-75,311	Closed	-$2.9M	–	303
2017 Q1	$2.9M	Sell	75,311 -38,641	-34%	-$1.16M	0.46%	94
2016 Q4	$2.52M	Sell	113,952 -80,772	-41%	-$1.66M	0.33%	154
2016 Q3	$3.12M	Buy	+194,724	New	+$2.22M	0.42%	77

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Investors's CC Position: Q2 2017 in Review

EAM Investors sold out of Chemours (CC) in Q2 2017, closing a stake of 75,311 shares — an estimated $2.9M sold.

EAM Investors first reported a position in CC in Q3 2016 and held it in 3 quarters. The position peaked at $3.12M in Q3 2016. 462 funds tracked by Wall St. Rank hold CC as of Q2 2017.

EAM Investors reported no remaining Chemours position as of Q2 2017 after selling out during the quarter.
EAM Investors sold 75,311 Chemours shares in Q2 2017, an estimated $2.9M.
EAM Investors first reported a position in Chemours in Q3 2016 and held it in 3 quarters.
EAM Investors's Chemours position peaked at $3.12M in Q3 2016.
462 funds tracked by Wall St. Rank held Chemours as of Q2 2017.

Based on EAM Investors's 13F filing for Q2 2017, filed 11 Aug 2017.